GALECTIN THERAPEUTICS INC. Convertible Preferred Stock, Shares Reserved for Future Issuance
GALECTIN THERAPEUTICS INC. (GALT) had Convertible Preferred Stock, Shares Reserved for Future Issuance of 1.01 million shares as of 2016-12-23, per its 10-K filed 2021-03-31.
Discontinued › Notes › Equity › Stockholders' Equity Note › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ConvertiblePreferredStockSharesReservedForFutureIssuance · last filed 2021-03-31
- 2016-12-23: Convertible Preferred Stock, Shares Reserved for Future Issuance 1.01M shares.
| Period end | Convertible Preferred Stock, Shares Reserved for Future Issuance |
|---|---|
| 2016-12-23 | 1.01M shares 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |